ProfileGDS5822 / ILMN_2839313
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 94% 73% 94% 93% 91% 80% 72% 82% 83% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 11029.594
GSM1276600PDAC Late Ablation Control 273.573
GSM1276601PDAC Late Ablation Control 31006.594
GSM1276602PDAC Late Ablation 1711.693
GSM1276603PDAC Late Ablation 2603.691
GSM1276604PDAC Late Ablation 3162.280
GSM1303940PDAC Late Ablation_anti-CTLA4 156.972
GSM1303941PDAC Late Ablation_anti-CTLA4 2236.182
GSM1303942PDAC Late Ablation_anti-CTLA4 3258.383